WSJ: Medtronic Takes Key Step Toward Automating Insulin Delivery for Diabetes Patients

Insulin-645x250

Medtronic Inc. (MDT) insulin pump designed to temporarily shut off was able to reduce the incidence of a potentially fatal condition that occurs when blood-sugar levels fall too low–a key advance in the effort to fully automate the delivery of insulin in diabetes patients.

Read more

Posted in Artificial Pancreas Glucose & Insulin